
7:15-8:00
Continental Breakfast at University of California Washington Center
8:00-8:15
Welcome and Introduction
Leslie Z. Benet
8:15-8:45
"The Need to Understand Within Subject Variability" (PDF)
Mats Karlsson (Uppsala University)
8:45-9:10
"Should We Expect to Be Able to Predict PK in Individual Patients?" (PDF)
Leslie Z. Benet (UCSF)
9:10-9:40
"Pharmacogenomics and PK Prediction in Individual Patients"
Kathleen M. Giacomini (UCSF)
9:40-10:10
"Systems Pharmacokinetics, the Basis for Prediction"
Malcolm Rowland (University of Manchester)
10:10-10:35
Coffee Break
10:35-11:05
"Pharmacodynamics and Disease Systems Analysis" (PDF)
Meindert Danhof (Leiden University)
11:05-11:35
"Optimal Design of Population PK/PD" (PDF)
France Mentre (INSERM)
11:35-12:05
"The Time Course of Drug Action – When PK is Not Needed"
Nicholas H. G. Holford (University of Auckland)
12:05-12:35
"Semi-Parametric Methods Applied to Modeling, Optimal Design and Model Selection" (PDF)
Davide Verotta (UCSF)
12:35-2:00
Lunch at the Beacon Hotel
2:00-2:30
"Connecting Models to Real LifeŅA Regulatory Perspective" (PDF)
Robert Powell (FDA)
2:30-3:00
"Creating the Sheiner Vision in the Pharmaceutical Industry: An Opportunity with Obstacles"
Donald Stanski (Novartis)
3:00-3:30
"Pharmacometric Guided Product Design" (PDF)
Suneel Gupta (ALZA)
3:30-3:55
Coffee Break
3:55-4:25
"Leveraging Quantitative Pharmacology in Drug Disposition"
Sandra Allerheiligen (Lilly)
4:25-4:55
"Simulations Using a Physiologic Based Drug-Drug Interaction Model: Individual Risk Assessment"
Roeline Jochemson (IRIS)
4:55-5:25
"Fitting PK/PD Models in the Biotech Landscape" (PDF)
Nancy Sambol (UCSF)
6:00
Banquet at Doubletree Hotel
7:45-8:30
Continental Breakfast at University of California Washington Center
8:30-9:00
"Validly Estimating True Dose-Response When Only Treatment vs. Control is Randomized" (PDF)
Donald B. Rubin (Harvard)
9:00-9:30
"Model Based Development of Anti-HIV Drugs" (PDF)
Terrence F. Blaschke (Stanford)
9:30-10:00
"From 'Pharmacokinetics/
Pharmacodynamics' to 'Modeling & Simulation' in Drug Development"
Jean Louis Steimer (Novartis)
10:00-10:30
Coffee Break
10:30-11:00
"Engineering the Transition to Model-Based Development"
Thaddeus Grasela (Cognigen Corporation)
11:00-11:30
"Putting Science into Drug Regulatory Science" (PDF)
Carl C. Peck (UCSF)
11:30-1:00
Lunch at the Beacon Hotel
1:00-1:30
"Creating Communicators: A Paradigm for Teaching Presentation" (PDF)
Tim Sheiner (Pharsight)
1:30-3:30
Panel Discussion and Audience Input. Discussants include: Richard C.
Brundage (University of Minnesota), Nicholas H.G. Holford (University
of Auckland), Mats Karlsson (Uppsala University), Dennis Fisher (The
"P Less Than" Company), Kyungsoo Park (Yonsei University)
3:30-3:40
Closing Remarks
Carl C. Peck
Lewis B Sheiner Memorial Symposium, Special Session for Former Colleagues
Improving Drug Development Using Patient Adherence Data
in Clinical Trials, May 6-7, 2008.
Brochure (PDF)
Registration site
Advanced NONMEM workshop – March 17–19, 2008 at Mission Bay Conference Center, San Francisco, CA.
More information >
UCSF-CDDS to launch The American Course on Drug Development and
Regulatory Science- September 2007
More information >
CDDS – Pharmacometric Services is available to drug researchers
More >
Howard Lee, MD, PhD, named Director of CDDS
More >
Lewis B. Sheiner Memorial. Symposium held at CDDS in December 2006
More >
This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.